Matthew Stern Selected Research

Matthew Stern Research Topics

25	Parkinson Disease (Parkinson's Disease) 02/2024 - 10/2002
5	Dyskinesias (Dyskinesia) 05/2011 - 01/2005
3	Anosmia 01/2020 - 11/2014
2	Prodromal Symptoms 01/2020 - 05/2013
2	Disruptive, Impulse Control, and Conduct Disorders (Kleptomania) 08/2014 - 05/2011
1	Dementia (Dementias) 02/2024
1	Cognitive Dysfunction 01/2022
1	Disorders of Excessive Somnolence (Hypersomnia) 05/2011
1	Movement Disorders (Movement Disorder) 01/2009
1	Cerebral Hemorrhage 01/2009
1	Bradycardia 10/2006

4	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2020 - 11/2014
4	Levodopa (L Dopa)FDA LinkGeneric 05/2011 - 04/2003
4	rasagiline (Azilect)FDA Link 05/2011 - 05/2006
3	Biomarkers (Surrogate Marker)IBA 02/2024 - 05/2013
3	Monoamine Oxidase (MAO)IBA 05/2011 - 05/2006
2	SynucleinsIBA 02/2024 - 05/2011
2	salicylhydroxamic acid (SHAM)IBA 08/2015 - 12/2010
2	NeurturinIBA 08/2015 - 12/2010
2	Dopamine Agonists (Dopamine Agonist)IBA 05/2011 - 04/2003
1	serum P-component (CIt)IBA 01/2020
1	Vitamin D FDA LinkGeneric 11/2017
1	Naltrexone (ReVia)FDA LinkGeneric 08/2014
1	Dopamine (Intropin)FDA LinkGeneric 05/2011
1	Selegiline (E250)FDA LinkGeneric 05/2011
1	Amantadine (Aman)FDA LinkGeneric 05/2011
1	Excitatory Amino Acid AntagonistsIBA 05/2011
1	ropinirole (Requip)FDA LinkGeneric 05/2010
1	TyramineIBA 10/2006
1	Carbidopa (Lodosyn)FDA LinkGeneric 02/2006
1	etilevodopaIBA 02/2006
1	Dopamine Agents (Dopaminergic Agents)IBA 01/2005
1	Proteins (Proteins, Gene)FDA Link 04/2003
1	alpha-SynucleinIBA 04/2003
1	coenzyme Q10 (CoQ10)IBA 10/2002

8	Deep Brain Stimulation 01/2022 - 04/2003
5	Therapeutics 06/2015 - 02/2006
2	Operative Surgical Procedures 06/2010 - 01/2009
1	Activities of Daily Living (ADL) 04/2016